For first trimester nausea and vomiting, treatment options are limited. In this large retrospective analysis of >81,000 pregnant women, the use of first trimester metoclopramide had no association with congenital malformations, low birth weight, preterm birth, or perinatal death (abstract). This give reassurance of the safety of first trimester metoclopramide use for nausea and vomiting.
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.